Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that it is initiating a Phase 2b study of narmafotinib in pancreatic cancer exploring a new dosing regimen.

Attackers are increasingly abusing Microsoft’s legacy MSHTA utility to silently deliver malware, stealers, and persistent ...

The Philadelphia-area physicians group has 275 practice locations serving 900,000 patients annually across three states.

MELBOURNE, Australia, May 19, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including ...

The state has attracted companies pursuing both fusion and fission nuclear power, alongside smaller firms building components ...

The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, ...

Researchers say the campaign uses a browser-based JavaScript VM to hide credential theft and intercept MFA at scale.

To expand opportunities for West Virginia University students and advance innovation at the intersection of artificial ...

OpenAI is expanding its India AI push with a Bengaluru-based hiring drive focused on startup deployments, enterprise AI ...

Republican senators in Louisiana have advanced a plan to eliminate one of two majority-Black U.S. House districts for this ...

A known Belarussian cyber-espionage group is back with a threat campaign against targets in Eastern Europe that uses spear-phishing to deliver malicious payloads to Eastern European government and ...

The proposed replacement hospital would cost about $1.64 billion, but the appropriations legislation — the first for the 2027 ...